Trials / Unknown
UnknownNCT04122599
Melatonin for Prevention of Post Stroke Delirium
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 2,000 (estimated)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
Post stroke delirium is prevalent in 10-30% of all stroke patients. We aimed to investigate wether Melatonin 2mg may prevent post stroke delirium.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melatonin | Melatonin for prevent post stroke delirium |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2019-11-01
- Completion
- 2019-12-31
- First posted
- 2019-10-10
- Last updated
- 2019-10-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04122599. Inclusion in this directory is not an endorsement.